Nora Fritschi
Overview
Explore the profile of Nora Fritschi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fritschi N, Heininger U
Vaccine
. 2025 Feb;
50:126850.
PMID: 39923543
Background: To minimize Bordetella pertussis transmission, health care workers (HCW) should be regularly vaccinated against pertussis, e.g. every 10 years. Therefore, the previous 2012/2013 vaccination campaign in our hospital was...
2.
Paganini A, Fritschi N, Filippi C, Ritz N, Simmen U, Scheinemann K, et al.
Sci Rep
. 2025 Jan;
15(1):3544.
PMID: 39875458
Salivary cytokines have the potential to serve as biomarkers for evaluating cancer progression and treatment response in specific cancer types. This study explored salivary cytokine profiles in pediatric cancer patients...
3.
Heeb L, Fritschi N, Marten A, Welzel T, Ritz N, Heininger U
Infection
. 2024 Sep;
PMID: 39325354
Background: Lyme borreliosis is one of the most prevalent tick-borne diseases in Europe. Studies on seroprevalence of Borrelia burgdorferi IgG antibodies in children are rare. The aim of this study...
4.
Fritschi N, Gureva T, Eliseev P, Jackson C, Milanzi E, Crichton S, et al.
PLoS One
. 2024 Aug;
19(8):e0293272.
PMID: 39190640
Background: A novel skin test-called Diaskintest (DT)-containing specific M. tuberculosis antigens is in clinical use in the Russian Federation (RF). This test may improve diagnosis of tuberculosis (TB) infection. The...
5.
Neudecker D, Fritschi N, Sutter T, Lu L, Lu P, Tebruegge M, et al.
BMC Infect Dis
. 2024 Jun;
24(1):629.
PMID: 38914934
No abstract available.
6.
Neudecker D, Fritschi N, Sutter T, Lu L, Lu P, Tebruegge M, et al.
BMC Infect Dis
. 2024 May;
24(1):481.
PMID: 38730343
Background: Tuberculosis (TB) poses a major public health challenge, particularly in children. A substantial proportion of children with TB disease remain undetected and unconfirmed. Therefore, there is an urgent need...
7.
Gasser N, Fritschi N, Egger J, Ritz N, Schoch O, Zellweger J
Respiration
. 2023 Oct;
102(11):934-943.
PMID: 37899038
Background: Children exposed to a tuberculosis (TB) index case are at risk of TB infection and disease. Objectives: The aim of this study was to describe the proportion of child...
8.
Kissling M, Fritschi N, Baumann P, Buettcher M, Bonhoeffer J, Naranbhai V, et al.
Pediatr Infect Dis J
. 2023 Mar;
42(6):520-527.
PMID: 36977187
Background: The neutrophil-to-lymphocyte-ratio (NLR), neutrophil-to-monocyte-plus-lymphocyte-ratio (NMLR) and monocyte-to-lymphocyte-ratio (MLR) may have diagnostic potential for tuberculosis (TB). Methods: Data of two prospective multicenter studies in Switzerland were used, which included children...
9.
Buonsenso D, Noguera-Julian A, Moroni R, Hernandez-Bartolome A, Fritschi N, Lancella L, et al.
Thorax
. 2022 Oct;
78(3):288-296.
PMID: 36283826
Rationale: In 2016, a new interferon-gamma release assay (IGRA) was introduced, QuantiFERON-TB Gold Plus (QFT-Plus), claimed to have improved sensitivity in active tuberculosis (TB). Objectives: This study aimed to determine...
10.
Rinderknecht C, Filippi C, Ritz N, Fritschi N, Simmen U, Filippi A, et al.
Sci Rep
. 2022 Sep;
12(1):15991.
PMID: 36163488
Human saliva is a complex fluid containing proteins such as salivary cytokines, which can be used for diagnostic purposes, particularly among the pediatric population. This study aimed to assess the...